Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
CALL
Host Hotels & Resorts
HST
$16B
| $341K | ﹤0.01% |
17,200
-400
| -2% | -$7.84K |
|
4152
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
| $341K | ﹤0.01% |
16,250
| – | – |
|
4153
Ryanair
RYAAY
$31.3B
| $341K | ﹤0.01% |
8,168
+7,843
| +2,413% | +$349K |
|
4154
CALL
ManpowerGroup
MAN
$2.63B
| $340K | ﹤0.01% |
2,700
+2,500
| +1,250% | +$312K |
|
4155
CALL
ProShares UltraShort QQQ
QID
$247M
| $340K | ﹤0.01% |
318
-131
| -29% | -$147K |
|
4156
Upbound Group
UPBD
$1.16B
| $340K | ﹤0.01% |
30,680
-13,203
| -30% | -$145K |
|
|
GCI
4157
CALL
DELISTED
Gannett Co., Inc
GCI
| $340K | ﹤0.01% |
29,300
+26,200
| +845% | +$274K |
|
4158
CALL
Principal Financial Group
PFG
$24.3B
| $339K | ﹤0.01% |
4,800
+1,700
| +55% | +$117K |
|
|
LGF.A
4159
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $339K | ﹤0.01% |
10,022
+5,204
| +108% | +$164K |
|
|
BBT
4160
Beacon Financial Corp
BBT
$2.66B
| $338K | ﹤0.01% |
9,222
+8,271
| +870% | +$315K |
|
4161
Franklin Electric
FELE
$4.84B
| $337K | ﹤0.01% |
7,349
+6,209
| +545% | +$280K |
|
|
ONIT
4162
CALL
Onity Group
ONIT
$332M
| $337K | ﹤0.01% |
7,187
+2,294
| +47% | +$115K |
|
|
KEM
4163
PUT
DELISTED
KEMET Corporation
KEM
| $337K | ﹤0.01% |
+22,400
| New | +$427K |
|
4164
CALL
Ameren
AEE
$30.1B
| $336K | ﹤0.01% |
5,700
+1,100
| +24% | +$67.6K |
|
4165
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $336K | ﹤0.01% |
15,138
+7,219
| +91% | +$169K |
|
|
FARO
4166
DELISTED
Faro Technologies
FARO
| $336K | ﹤0.01% |
7,136
+6,725
| +1,636% | +$315K |
|
4167
CALL
Hecla Mining
HL
$11.3B
| $336K | ﹤0.01% |
84,700
-88,500
| -51% | -$385K |
|
|
AYR
4168
DELISTED
Aircastle Ltd
AYR
| $336K | ﹤0.01% |
14,358
-2,537
| -15% | -$59.6K |
|
4169
Alaunos Therapeutics
TCRT
$4.86M
| $335K | ﹤0.01% |
540
+145
| +37% | +$104K |
|
|
SUPV
4170
Grupo Supervielle
SUPV
$753M
| $334K | ﹤0.01% |
11,400
| – | – |
|
4171
Vanguard Total World Stock ETF
VT
$79.8B
| $334K | ﹤0.01% |
4,495
| – | – |
|
|
ITCI
4172
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $334K | ﹤0.01% |
23,100
| – | – |
|
4173
Cohen & Steers
CNS
$4.3B
| $333K | ﹤0.01% |
7,043
+5,901
| +517% | +$260K |
|
4174
CALL
Jabil
JBL
$35.8B
| $333K | ﹤0.01% |
12,700
-14,500
| -53% | -$411K |
|
|
PRTK
4175
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $333K | ﹤0.01% |
18,605
+52
| +0.3% | +$1.08K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.